Table 2 Sociodemographic and HCV-related risk behaviours in the last 6 months at study baseline
Sociodemographic and HCV-related risk behaviours at study baseline | Total (n = 118) | Participants without nsCAI (n = 46) | Participants with nsCAI (n = 72) | Univariable Odds Ratio (95% CI) | Multivariable Adjusted OR (95% CI) for age and HCV duration | Adjusted OR (95% CI) for HCV duration |
|---|---|---|---|---|---|---|
Age, mean (sd) | 46.6 (+/− 9.2) | 49.0 (+/− 9.1) | 45.1 (+/− 9.1) | 0.64 (0.41, 0.96)a | ||
HCV duration, median (IQR) | 2.9 (1.1–7.1) | 4.8 (2.1–10.3) | 1.9 (0.9–5.1) | 0.87 (0.80, 0.94) | ||
Sharing sextoys, n (%) (n = 104/38/66)b | 25 (24) | 7 (18) | 18 (28) | 1.53 (0.58, 4.40) | 1.05 (0.36, 3.21) | 1.08 (0.37, 3.29) |
Fisting, n (%) (n = 114/43/71)b | 28 (25) | 7 (16) | 21 (30) | 2.02 (0.80, 5.62) | 2.12 (0.78, 6.31) | 1.92 (0.72, 5.60) |
Drug use, n (%) (n = 117/45/72)b | 52 (44) | 8 (18) | 44 (61) | 7.27 (3.08, 18.91) | 5.58 (2.26, 15.02) | 5.79 (2.37, 15.42) |
GHB/GBL, n (%) | 30 (26) | 3 (7) | 27 (38) | 8.60 (2.78, 37.87) | 6.64 (2.04, 30.18) | 6.91 (2.15, 31.07) |
Cocaine, n (%) | 26 (22) | 6 (13) | 20 (28) | 2.56 (0.99, 7.55) | 2.36 (0.85, 7.39) | 2.49 (0.91, 7.6) |
Crystal methamphetamine, n %) | 22 (19) | 1 (2) | 21 (29) | 18.48 (3.63, 338.0) | 15.47 (2.89, 288.31) | 15.91 (3.01, 294.78) |
Ketamine, n (%) | 11 (9) | 2 (4) | 9 (14) | 3.12 (0.76, 21.14) | 3.55 (7.82, 25.71) | 3.55 (7.82, 25.71) |
Mephedrone, n (%) | 10 (9) | – | 10 (15) | |||
Use of any of the drugs listed above during sex, n (%) (n = 116/45/71)b | 44 (38) | 7 (16) | 37 (52) | 5.90 (2.44, 16.05) | 4.42 (1.73, 12.52) | 4.63 (1.84, 12.92) |
Reporting injection of drugs, n (%) (n = 117/45/72)b | 17 (15) | 2 (4) | 15 (21) | 5.66 (1.49, 37.12) | 4.45 (1.10, 30.15) | 4.53 (1.13, 30.51) |